Pacific Center for Financial Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.3K | Hold |
123
| – | – | ﹤0.01% | 286 |
|
|
2026
Q1 | $18.8K | Hold |
123
| – | – | ﹤0.01% | 276 |
|
|
2025
Q4 | $15.8K | Hold |
123
| – | – | ﹤0.01% | 286 |
|
|
2025
Q3 | $15.8K | Hold |
123
| – | – | ﹤0.01% | 286 |
|
|
2025
Q2 | $14.9K | Hold |
123
| – | – | ﹤0.01% | 282 |
|
|
2025
Q1 | $13.7K | Hold |
123
| – | – | ﹤0.01% | 283 |
|
|
2024
Q4 | $12K | Hold |
123
| – | – | ﹤0.01% | 291 |
|
|
2024
Q3 | $14.1K | Hold |
123
| – | – | ﹤0.01% | 277 |
|
|
2024
Q2 | $13.1K | Hold |
123
| – | – | ﹤0.01% | 278 |
|
|
2024
Q1 | $11.9K | Hold |
123
| – | – | ﹤0.01% | 287 |
|
|
2023
Q4 | $12.4K | Hold |
123
| – | – | ﹤0.01% | 263 |
|
|
2023
Q3 | $12.5K | Hold |
123
| – | – | ﹤0.01% | 266 |
|
|
2023
Q2 | $12.4K | Hold |
123
| – | – | ﹤0.01% | 263 |
|
|
2023
Q1 | $11.3K | Buy |
+123
| New | +$10.7K | ﹤0.01% | 266 |
|
|
2022
Q3 | $19K | Hold |
248
| – | – | 0.01% | 235 |
|
|
2022
Q2 | $21K | Hold |
248
| – | – | 0.01% | 224 |
|
|
2022
Q1 | $22K | Hold |
248
| – | – | 0.01% | 225 |
|
|
2021
Q4 | $22K | Hold |
248
| – | – | 0.01% | 228 |
|
|
2021
Q3 | $20K | Sell |
248
-2
| -0.8% | -$180 | 0.01% | 232 |
|
|
2021
Q2 | $23K | Hold |
250
| – | – | 0.01% | 211 |
|
|
2021
Q1 | $21K | Hold |
250
| – | – | 0.01% | 206 |
|
|
2020
Q4 | $24K | Hold |
250
| – | – | 0.01% | 191 |
|
|
2020
Q3 | $22K | Hold |
250
| – | – | 0.01% | 170 |
|
|
2020
Q2 | $22K | Hold |
250
| – | – | 0.01% | 160 |
|
|
2020
Q1 | $21K | Hold |
250
| – | – | 0.01% | 149 |
|
|
2019
Q4 | $24K | Hold |
250
| – | – | 0.01% | 166 |
|
|
2019
Q3 | $22K | Hold |
250
| – | – | 0.01% | 169 |
|
|
2019
Q2 | $23K | Sell |
250
-29
| -10% | -$2.45K | 0.01% | 162 |
|
|
2019
Q1 | $24K | Hold |
279
| – | – | 0.01% | 152 |
|
|
2018
Q4 | $21K | Hold |
279
| – | – | 0.01% | 159 |
|
|
2018
Q3 | $22K | Hold |
279
| – | – | 0.01% | 163 |
|
|
2018
Q2 | $19K | Hold |
279
| – | – | 0.01% | 160 |
|
|
2018
Q1 | $20K | Hold |
279
| – | – | 0.01% | 154 |
|
|
2017
Q4 | $21K | Hold |
279
| – | – | 0.01% | 148 |
|
|
2017
Q3 | $21K | Hold |
279
| – | – | 0.01% | 145 |
|
|
2017
Q2 | $21K | Hold |
279
| – | – | 0.01% | 143 |
|
|
2017
Q1 | $19K | Hold |
279
| – | – | 0.01% | 143 |
|
|
2016
Q4 | $18K | Buy |
+279
| New | +$18.1K | 0.01% | 151 |
|
Other funds holding NVS
Pacific Center for Financial Services's NVS Position: Q2 2026 in Review
Pacific Center for Financial Services held its Novartis (NVS) position steady in Q2 2026 at 123 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #286.
Pacific Center for Financial Services first reported a position in NVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $24K in Q4 2020. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Pacific Center for Financial Services held 123 shares of Novartis worth $19.3K as of Q2 2026.
- Pacific Center for Financial Services left its Novartis share count unchanged in Q2 2026.
- Novartis made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q2 2026, its #286 holding.
- Pacific Center for Financial Services first reported a position in Novartis in Q4 2016 and has held it in 38 quarters since.
- Pacific Center for Financial Services's Novartis position peaked at $24K in Q4 2020.
- 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.